Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Regulatory press release

MedCap AB: MedCap's Business Area Specialty Pharma Completes the Acquisition of XGX Pharma

MedCap
Download the release

MedCap's wholly owned subsidiary, Unimedic Pharma AB, has today completed the previously announced acquisition of 100% of the shares in XGX Pharma ApS ("XGX") in Denmark.

The acquisition was announced on June 25, 2025, and has now received the necessary regulatory approval (Foreign Direct Investment) in Denmark.

The information was submitted for publication, through the agency of the contact person, on 21-07-2025 12:00 CEST.

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.